InvestorsHub Logo

bow-tie

05/02/21 5:15 PM

#24627 RE: steel8000 #24626

Please be a moderator and fill that last position with MYMX :)

Work Harder

05/02/21 5:58 PM

#24628 RE: steel8000 #24626

Yes sir

Relief is a biopharmaceutical company founded by former Merck executives (Serono division) whose objective is to provide patients with therapeutic relief in serious diseases with high unmet medical need.

https://relieftherapeutics.com/company

Relief Therapeutics: In-Licensing Agreement with Merck

https://www.startupticker.ch/en/news/september-2015/relief-therapeutics-in-licensing-agreement-with-merck

Relief Therapeutics SA has executed, on 28 August 2015, a license agreement with Ares Trading SA, a wholly-owned subsidiary of Merck KGaA ("Merck”), for the exclusive, worldwide right to research, develop, use and commercialize atexakin alfa ("Atexakin”, or the "Molecule” or "SON-080” or the "Asset”). Atexakin is a low-dosage formulation of interleukin-6 (IL-6), a natural mammalian cytokine of 185 amino acids with pleiotropic functions in different tissues and organs for which clinical Phase I/II studies were conducted in thrombocytopenic cancer patients by Serono International ("Serono”), later acquired by Merck. Additional pre-clinical results generated by Serono in specific animal models have demonstrated the ability of Atexakin to regrow nerves and reinstate their normal functions, suggesting its potential to treat a cluster of diseases referred to as neuropathies.

https://markets.businessinsider.com/news/stocks/relief-therapeutics-holding-sa-announces-divestment-of-its-subsidiary-relief-therapeutics-sa-to-sonnet-biotherapeutics-inc-to-ensure-the-development-of-atexakin-alpha-interleukin-6-1028436854

About NeuroRx, Inc.

drug development projects for Merck, Allergan, Pharmacia, Pfizer, Novartis, and Mannkind,

https://www.marketscreener.com/quote/stock/RELIEF-THERAPEUTICS-HOLDI-120797827/news/Relief-Therapeutics-nbsp-C-O-R-R-E-C-T-I-O-N-NeuroRx-32822986/

RELIEF COMMENTS ON CERTAIN STATEMENTS MADE BY NEURORX, INC. IN THE AMENDED FORM S-4 FILING OF BIG ROCK PARTNERS ACQUISITION CORP.
19 April 2021

https://relieftherapeutics.com/newsblog/relief-comments-on-certain-statements-made-by-neurorx-inc-in-the-amended-form-s-4-filing-of-big-rock-partners-acquisition-corp

MERCK SERONO SA AND ARES TRADING SA GENERALCONDITIONS OF PURCHASE (GOODS/SERVICES)

https://webcache.googleusercontent.com/search?q=cache:pIaIkxFkE8oJ:https://www.merckgroup.com/content/dam/web/corporate/non-images/company/contacts/supplier/en/standard-tac/Swiss_Standard_TaC_EN.pdf+&cd=9&hl=en&ct=clnk&gl=us

https://www.google.com/maps/place/Ares+Trading+SA+%7C/@46.429311,6.0492896,10.25z/data=!4m5!3m4!1s0x478c5d8d54ecdb89:0xc31d65a162fb3ad1!8m2!3d46.3839803!4d6.2089816

Change of name from 'Ares Trading SA' to 'ARES TRADING SA'

https://opencorporates.com/companies/ch/8343